•  Summary 
  •  
  •  Actions 
  •  
  •  Committee Votes 
  •  
  •  Floor Votes 
  •  
  •  Memo 
  •  
  •  Text 
  •  
  •  LFIN 
  •  
  •  Chamber Video/Transcript 

A01461 Summary:

BILL NOA01461A
 
SAME ASSAME AS S00893-A
 
SPONSORPaulin
 
COSPNSRSayegh, Steck, Simon, Cook, Glick, Vanel, Lunsford, Rosenthal, Bronson, Williams, Bichotte Hermelyn, Carroll R, Fall, Gallagher, Forrest, Cruz, Stirpe, Clark, Colton, Santabarbara, Hunter, Jackson, Zinerman, Kelles, Jacobson, Otis, Meeks, Weprin, Raga
 
MLTSPNSR
 
Add §280-e, Pub Health L
 
Relates to the use of antipsychotic medications in nursing homes; imposes limits as to time and documentation; requires informed consent under certain circumstances.
Go to top

A01461 Text:



 
                STATE OF NEW YORK
        ________________________________________________________________________
 
                                         1461--A
 
                               2025-2026 Regular Sessions
 
                   IN ASSEMBLY
 
                                     January 9, 2025
                                       ___________
 
        Introduced by M. of A. PAULIN, SAYEGH, STECK, SIMON, COOK, GLICK, VANEL,
          LUNSFORD, ROSENTHAL, BRONSON, WILLIAMS, BICHOTTE HERMELYN, R. CARROLL,
          FALL,  GALLAGHER,  FORREST, CRUZ, STIRPE, CLARK, COLTON, SANTABARBARA,
          HUNTER, JACKSON, ZINERMAN, KELLES, JACOBSON, OTIS, MEEKS, WEPRIN, RAGA
          -- read once and referred to the  Committee  on  Health  --  committee
          discharged, bill amended, ordered reprinted as amended and recommitted
          to said committee
 
        AN ACT to amend the public health law, in relation to the use of psycho-
          tropic medications in nursing homes and adult care facilities
 
          The  People of the State of New York, represented in Senate and Assem-
        bly, do enact as follows:
 
     1    Section 1. The public health law is amended by adding  a  new  section
     2  280-e to read as follows:
     3    §  280-e.  Use  of  antipsychotic medications in nursing homes.  1. As
     4  used in this section:
     5    (a) "lawful representative" means, where a resident lacks capacity  to
     6  consent  to health care, a person authorized to consent on behalf of the
     7  resident, including, but not limited to, a health care agent  authorized
     8  by  a health care proxy under article twenty-nine-C of this chapter or a
     9  surrogate under article twenty-nine-CC of this chapter; and
    10    (b) "health care  professional"  means  a  health  care  professional,
    11  licensed,  certified  or authorized to practice under title eight of the
    12  education law, acting within  such  health  care  professional's  lawful
    13  scope  of  practice, who has authority to order an antipsychotic medica-
    14  tion.
    15    2. (a) A nursing home or a health care professional shall  obtain  the
    16  informed written consent of the resident or the resident's lawful repre-
    17  sentative,  before  initiating  the  administration  of an antipsychotic
    18  medication for a resident, provided that informed written consent  shall
    19  not be required in the case of:
 
         EXPLANATION--Matter in italics (underscored) is new; matter in brackets
                              [ ] is old law to be omitted.
                                                                   LBD02250-06-5

        A. 1461--A                          2
 
     1    (i)  a  resident  who  has been prescribed an antipsychotic medication
     2  prior to an admission or readmission to the nursing home;
     3    (ii)  a  resident who has provided informed written consent within the
     4  last twelve months;
     5    (iii) a resident receiving hospice care;
     6    (iv) a resident of a nursing home's certified behavioral unit;
     7    (v) a resident with a primary diagnosis of Huntington's disease; or
     8    (vi) an emergency as defined in subdivision three of this section.
     9    (b) Where a resident lacks capacity to  consent  to  health  care  and
    10  lacks  a  lawful representative, a prescription under this section shall
    11  be subject to subdivision four of section  twenty-nine  hundred  ninety-
    12  four-g of this chapter as if the resident were an inpatient of a general
    13  hospital.  To constitute informed written consent, the following disclo-
    14  sure shall be given to the resident or, where the resident lacks capaci-
    15  ty to consent to health care, the resident's lawful representative, in a
    16  clear and explicit manner:
    17    (i) the reason for the medication, including the nature  and  serious-
    18  ness  of  the resident's illness, disorder or condition that the medica-
    19  tion is intended to treat;
    20    (ii) the anticipated benefit from the medication, and the dosage,  and
    21  frequency;
    22    (iii)  the  probability  of  side effects and significant risks of the
    23  medication, including the nature, degree, and duration of  such  effects
    24  and reasonably known risks;
    25    (iv)  the reasonable alternative treatments to the proposed medication
    26  and the reason that the prescribing health care professional prefers the
    27  proposed medication in this instance; and
    28    (v) that the resident  or  lawful  representative  has  the  right  to
    29  consent or refuse consent to use of the proposed medication, and that if
    30  such resident or lawful representative consents, such resident or lawful
    31  representative  has the right to revoke such resident's or lawful repre-
    32  sentative's consent for any reason, at any time, including a description
    33  of how the consent shall be revoked.
    34    (c) The health care professional  shall  document  in  the  resident's
    35  medical  record  the  date  and  time  that the informed written consent
    36  disclosure was provided, and to whom and by whom it was provided.
    37    (d) Where the resident's medical record notes that a family member has
    38  requested notification of medication orders or prescriptions,  and  such
    39  notification  is  otherwise  lawful,  the health care professional shall
    40  cause notice to be provided within forty-eight hours of the order  under
    41  this  section. Such notice shall not be provided if the resident specif-
    42  ically requests that the family member not be given notification.
    43    3. A nursing home and a health care professional shall not be required
    44  to obtain consent under this section to issue an order  for  use  of  an
    45  antipsychotic  medication  for  a resident in a nursing home where it is
    46  necessary in an emergency to protect against an immediate threat to  the
    47  life,  health  or safety of the resident or another person.  The medica-
    48  tion must be the most  appropriate  available  means  of  reducing  that
    49  threat, with the least risk of harm considering the resident's condition
    50  or  disorder.  The  order  shall  only apply, in the absence of consent,
    51  during the emergency. Where an order is made under this subdivision, the
    52  health care professional shall immediately record the use of  the  anti-
    53  psychotic  medication,  the  reason  for the use, and the dosage, in the
    54  resident's medical record; and shall promptly notify the resident or the
    55  resident's lawful representative who would have  had  the  authority  to

        A. 1461--A                          3
 
     1  consent,  and  any  family  member  required  to  be notified under this
     2  section and record such notifications in the resident's medical record.
     3    4.  This section does not increase the lawful scope of practice of any
     4  health care professional and does not diminish or impair any requirement
     5  for or regulation of consent to health care treatment.
     6    5. The commissioner may make regulations to implement this section.
     7    § 2. This act shall take effect one year after it shall have become  a
     8  law. Effective immediately, the addition, amendment and/or repeal of any
     9  rule  or  regulation necessary for the implementation of this act on its
    10  effective date are authorized to be made and completed on or before such
    11  effective date.
Go to top